BGI Genomics

New partnership with GORTEC China to strengthen head and neck cancer research. 🧬🤝 On August 16, BGI Genomics announced a collaboration with the China–France Head and Neck Cancer Joint Research Group (GORTEC China) , officially launched the same day in Shanghai. Under the agreement, the two parties will jointly conduct multicenter research on minimal residual disease (MRD) and advance the clinical application of BGI Genomics' multiplex immunofluorescence technology in precision diagnosis and treatment. Bringing together clinical expertise and genomic innovation to improve detection, monitoring, and treatment guidance for head and neck cancer patients. 🔬 Read more: https://lnkd.in/g_aU8H5k #HeadAndNeckCancer #MRD #PrecisionMedicine #Oncology #BGIGeneTest #omicsforall #GORTEC

BGI Genomics' next‑generation Automated Sample Preparation System MSP‑800 has officially received China Class II medical device registration – with international promotion underway. This new milestone of BGI Genomics' clinical mass spectrometry automation has four core upgrades driving lab efficiency: ⚡ Extreme Speed – 8‑channel parallel pipetting, 2× faster than previous generation MSP-400 💰 Radical Cost Reduction – Steel needle with inline washing reduces tip consumption; no minimum batch size – run 1 to 96 samples flexibly 🧠 Intelligent Stability – Smart monitoring, automatic error alarms, and built‑in liquid level/dot detection 🛡️ Simple & Safe – Fully enclosed, UV disinfection, touchscreen interface, saves bench space Building on the MSP‑400, the MSP‑800 completes the "Tube in, Plate out" automated workflow – freeing lab professionals from tedious manual tasks to focus on higher‑value work. Contact our local team or email [email protected] for a quote. #MassSpectrometry #LabAutomation #ClinicalDiagnostics #BGIGeneTest Learn more 👇 https://lnkd.in/gGyWVcWZ

We're hiring! 🧬🚀 Want to be part of a global community that believes in #OmicsForAll? At BGI Genomics, we're looking for passionate people to help make genomics accessible, affordable, and impactful for everyone. 📌 Explore open roles on our Career Page (link below 👇) https://lnkd.in/gQM2R2fe 📩 Or send your CV and cover letter directly to our HR team. Let's get started — together. #Genomics #BGIGeneTest #Hiring #LifeSciences #nowhiring #recruiting

Underused PCR lab？BGI Sample Star-16 transforms it to a working colorectal cancer screening service - Client Story Many PCR labs have the space, equipment, and skilled staff – but fluctuating testing demand leaves capacity idle. A municipal hospital in China turned that underused lab into a daily colorectal cancer screening workflow using BGI Sample Star‑16 for automated nucleic acid extraction. The result: ✅ Scalable throughput – ~26 samples/day with one technologist ✅ Operational consistency – automated pre‑analytical steps reduce manual variation ✅ Low recollect rate – only 10 of ~900 stool samples needed re‑testing ✅ Clinical impact – 12 of 15 colonoscopy‑positive cases detected adenomas Key takeaway for labs: Stool DNA methylation testing + automation turns existing PCR capacity into a sustainable, high‑value cancer prevention service. 📖 Read the full case study: https://lnkd.in/gcu8bwMu #BGIGeneTest #ColorectalCancer #CRCScreening #StoolDNA #SampleStar16 #Automation #PCRLab #EarlyDetection

🩸🎗️Blood cancer – and #leukemia in particular – is not one cancer. It's many. Four main types (AML, ALL, CLL, CML) each have distinct biology and behavior. Even within the same type, molecular profiles vary widely. That's why global guidelines recommend MICM (morphology, immunology, cytogenetics, and molecular biology). Only by seeing the full genomic picture can we guide precise, targeted intervention. #BGIGenomics' SENTIS™ Leukemia Gene Detection delivers that molecular layer with two tailored options: 🔬 DNA+RNA – 373 genes + 1,000+ fusions (SNVs, InDels, CNVs, fusions) 🔬 DNA – 183 core genes for prognostic & hereditary risk From newly diagnosed to relapse, pre‑transplant to remission monitoring – comprehensive genomics guides targeted therapy, risk stratification, and MRD tracking. On #WorldBloodCancerDay today, Let's read it right. 👇 Learn more https://lnkd.in/gxmYRUKn #SENTIS #PrecisionOncology #BGIGeneTest #MolecularDiagnostics #MICM

Genos‑m: an open‑source DNA foundation model built for human‑associated microbes. 🧬🤖 BGI Genomics, BGI · Research and 之江实验室 Zhejiang Lab just released Genos‑m – designed specifically for the microbial world inside and around us (commensals, pathogens, phages, across major body sites). #Opensource (Apache 2.0) on #GitHub and #HuggingFace. Why it matters: ✅ Sparse MoE architecture (4.7B params, only ~330M activated) – efficient & powerful ✅ 1 Mbp context – from short genes to whole genomes ✅ Outperforms or matches much larger general‑purpose models (even Evo2‑40B) ✅ Real‑world impact: colorectal cancer risk modelling, and stable embeddings from as few as 10,000 metagenomic reads 👇 More about Genos-m model: https://lnkd.in/gsrFixDa #GenosM #Microbiome #FoundationModel #AIforScience #BGIGeneTest #Metagenomics #DNA #omicsforall